Literature DB >> 22112492

Stomach - Genetic and epigenetic alterations of preneoplastic and neoplastic lesions.

Stefan David1, Stephen J Meltzer.   

Abstract

Gastric cancer is one of the most common neoplasias in the world and remains an important cause of cancer-related mortality. Vast resources have been invested in the study of the molecular events driving the development and progression of gastric tumors. Gastric cancer is known to result from an interaction between host and environmental factors. The present review will discuss the most how genetic and epigenetic changes contribute to gastric carcinogenesis and their potential for developing novel diagnostic and therapeutic tools.

Entities:  

Mesh：

Year:  2010        PMID： 22112492     DOI： 10.3233/CBM-2011-0169

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN： 1574-0153            Impact factor:   4.388


  11 in total

1.  DNA hypermethylation of the vimentin gene inversely correlates with vimentin expression in intestinal- and diffuse-type gastric cancer.

Authors:  Hui Cong; Ru-Yong Yao; Zhen-Qing Sun; Wen-Sheng Qiu; Ya-Sai Yao; Tong-Tong Feng; Chao Xin; Jun Liang; L U Yue
Journal:  Oncol Lett       Date:  2015-11-18       Impact factor: 2.967

2.  Upregulation of miR-513b inhibits cell proliferation, migration, and promotes apoptosis by targeting high mobility group-box 3 protein in gastric cancer.

Authors:  Xudong Chen; Guoqiang Zhao; Fuqing Wang; Fenglan Gao; Hailan Luo; Yuanyuan Wang; Yuwen Du; Xiaonan Chen; Changgui Xue; Ziming Dong; Guohua Song
Journal:  Tumour Biol       Date:  2014-08-06

Review 3.  Epigenetic changes in carcinogenesis of gallbladder.

Authors:  Mallika Tewari; Amit Agarwal; R R Mishra; R N Meena; Hari S Shukla
Journal:  Indian J Surg Oncol       Date:  2013-04-04

Review 4.  Helicobacter pylori infection and gastric carcinoma: Not all the strains and patients are alike.

Authors:  Natale Figura; Luigi Marano; Elena Moretti; Antonio Ponzetto
Journal:  World J Gastrointest Oncol       Date:  2016-01-15

5.  CD81 is a candidate tumor suppressor gene in human gastric cancer.

Authors:  Tae-Hyoung Yoo; Byung-Kyu Ryu; Min-Goo Lee; Sung-Gil Chi
Journal:  Cell Oncol (Dordr)       Date:  2012-12-21       Impact factor: 6.730

Review 6.  Challenges of deciphering gastric cancer heterogeneity.

Authors:  Petra Hudler
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

7.  Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer.

Authors:  Zhi-Qiang Ling; Ping Lv; Xiao-Xiao Lu; Jiang-Liu Yu; Jing Han; Li-Sha Ying; Xin Zhu; Wang-Yu Zhu; Xian-Hua Fang; Shi Wang; Yi-Chen Wu
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

Review 8.  Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers.

Authors:  Hua-Hsi Wu; Wen-chang Lin; Kuo-Wang Tsai
Journal:  Expert Rev Mol Med       Date:  2014-01-23       Impact factor: 5.600

Review 9.  Gastric Cancer in the Era of Precision Medicine.

Authors:  Xi Liu; Stephen J Meltzer
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-02-20

10.  Association of childhood chronic physical aggression with a DNA methylation signature in adult human T cells.

Authors:  Nadine Provençal; Matthew J Suderman; Claire Guillemin; Frank Vitaro; Sylvana M Côté; Michael Hallett; Richard E Tremblay; Moshe Szyf
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.